CRISPR Therapeutics

Framingham, MA, USA

The project, which was completed in 2021, is a new 113,000 SF manufacturing facility for the biopharmaceutical company. CRISPR Therapeutics is a gene-editing company focused on developing medicines for serious diseases using its proprietary technology. This facility will be used for the clinical and commercial production of CRISPR Therapeutic’s investigational cell therapy products.

Project Highlights

• Application: Clean Rooms & Manufacturing Suites
• 175+ AccuValve low-pressure drop airflow control valves
• Controls by ATC for flexibility